B. 贖回/購回股份 (擬註銷但截至期終結存日期尚未註銷) (註5及6) FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 國恩控股有限公司 呈交日期： 2025年9月9日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 08121 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | ...

香港聯合交易所有限公司 （香港交易及結算所有限公司的全資附屬公司） 附錄五 上市申請表格 G 表格 GEM Page 1 of 4 December 2023 Form G FF003G 公司資料報表 香港交易及結算所有限公司及香港聯合交易所有限公司對本資料報表之內容概不負責，對其準確性或完整性亦不發 表任何聲明，並明確表示，概不對因本資料報表全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承 擔任何責任。 | | | 股份代號（普通股）： 8121 本資料報表列載若干有關上述在香港聯合交易所有限公司（「交易所」）GEM 上市之公司（「該公司」）之資料。 該等資料乃遵照香港聯合交易所有限公司《GEM 證券上市規則》（「《GEM 上市規則》」）之規定而提供，旨在 向公眾提供有關該公司之資料。該等資料將會在互聯網之 GEM 網頁展示。本資料報表不應視作有關該公司及／或 其證券之完整資料概要。 本報表的資料乃於 二零二五年九月八日更新。 A. 一般資料 | 註冊成立地點： | 開曼群島 | | --- | --- | | 在 GEM 首次上市日期： | 二零一五年五月二十九日 | | 保薦人名稱： | 不適 ...

Core Viewpoint - Guoen Holdings (08121) has successfully completed a placement agreement, with all conditions met as of September 8, 2025, resulting in the issuance of 5 million shares at a price of HKD 0.60 per share, representing approximately 16.66% of the total issued shares post-completion [1]. Summary by Category - **Company Actions** - The company has completed a placement agreement, successfully issuing a total of 5 million shares [1]. - The placement price was set at HKD 0.60 per share [1]. - **Shareholder Impact** - The newly issued shares account for approximately 16.66% of the total issued shares immediately following the completion of the placement [1]. - **Investor Participation** - The shares were successfully placed to no fewer than six subscribers [1].

Core Viewpoint - The announcement from Guo'en Holdings (08121) indicates that all conditions of the placement agreement have been met, and the completion occurred on September 8, 2025, with a total of 5 million placement shares successfully allocated at a price of HKD 0.60 per share, representing approximately 16.66% of the issued shares post-completion [1]. Summary by Categories - **Placement Details** - A total of 5 million placement shares were successfully allocated to no fewer than six subscribers [1]. - The placement price was set at HKD 0.60 per share [1]. - **Impact on Issued Shares** - The allocated shares represent approximately 16.66% of the total issued shares immediately after the completion of the placement [1].

本 公 佈 僅 供 參 考，並 不 構 成 收 購、購 買 或 認 購 本 公 司 證 券 的 邀 請 或 要 約。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 佈 全 部 或 任 何 部 份 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任。 Guoen Holdings Limited 國恩控股有限公司 （股份代號：8121） （於開曼群島註冊成立的有限公司） 完成根據一般授權配售新股份 茲 提 述 國 恩 控 股 有 限 公 司（「本公司」）日 期 為 二 零 二 五 年 八 月 二 十 一 日 有 關 配 售 事 項 之 公 佈（「該公佈」）。除 另 有 界 定 者 外，本 公 佈 所 用 之 詞 彙 與 該 公 佈 所 界 定 者 具 有 相 同 涵 義。 | 股 東 | | | 緊接完成前 | | 緊隨完成後 | | | --- | --- | --- | --- | --- | --- | --- ...

致：香港交易及結算所有限公司 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 公司名稱: 國恩控股有限公司 （於開曼群島註冊成立的有限公司） 呈交日期: 2025年9月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 08121 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.01 HKD | | | 100,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.01 HKD | ...

Core Viewpoint - The company has signed a placement agreement with a placement agent to issue up to 5 million shares at a price of HKD 0.60 per share, representing an approximate 11.76% discount to the previous closing price of HKD 0.680 [1] Group 1 - The maximum net proceeds from this placement are expected to be HKD 2.7 million [1] - The company plans to utilize the entire net proceeds to support the development of its healthcare business, which includes hiring talent, covering daily expenses of Shandong Guoen, conducting marketing activities, and developing sales platforms [1]

Core Viewpoint - The company, Guo'en Holdings (08121), has announced a placement agreement to issue up to 5 million shares at a price of HKD 0.60 per share, representing an approximate discount of 11.76% from the market price on the agreement date [1] Group 1: Placement Details - The placement will be conducted through a placement agent to no fewer than six independent third-party subscribers [1] - The estimated net proceeds from the placement are approximately HKD 2.7 million [1] Group 2: Use of Proceeds - The company intends to use the net proceeds entirely to support the development of its healthcare business, which includes hiring suitable talent, covering daily expenses of Shandong Guo'en, launching marketing activities, and developing sales platforms [1]

Group 1 - The core point of the article is that Guo En Holdings (stock code: 8121) announced a new share placement to raise approximately HKD 30 million, with net proceeds expected to be around HKD 27 million after expenses [1] - The placement involves issuing up to 5,000,000 new shares at a price of HKD 0.60 per share, which represents an 11.8% discount compared to the previous closing price of HKD 0.68 [1] - The new shares will account for approximately 20.0% of the existing issued share capital and about 16.7% of the enlarged share capital after the placement [1] Group 2 - The funds raised will primarily support the development of the company's healthcare business, including hiring talent, covering daily expenses, conducting marketing activities, and developing sales platforms [1] - The placement is conducted under a general mandate granted by the shareholders' meeting and is expected to be completed within five business days after the fulfillment of the placement agreement's conditions [1]

Core Viewpoint - The company, Guoen Holdings (08121), has announced a placement agreement to issue up to 5 million shares at a price of HKD 0.60 per share, representing an approximate discount of 11.76% from the closing price of HKD 0.680 on the date of the agreement [1] Group 1 - The placement is conditional and will be made to no less than six independent third-party investors [1] - The estimated net proceeds from the placement are approximately HKD 2.7 million [1] - The funds raised will be used to support the development of the company's healthcare business, including hiring suitable talent, covering daily expenses of Shandong Guoen, launching marketing activities, and developing sales platforms [1]